Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6WCO

Structure of SARS main protease bound to inhibitor X47

Summary for 6WCO
Entry DOI10.2210/pdb6wco/pdb
Related6W79
DescriptorMain protease, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclopentylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide, ... (5 entities in total)
Functional Keywordscovid-19, sars, sars-cov, main protease, 3c-like protease, 3cl protease, 3clpro, mpro, broad-spectrum, inhibitor, proteinase, non-covalent, reversible, structural genomics, center for structural genomics of infectious diseases, csgid, antiviral protein, viral protein, viral protein-inhibitor complex, viral protein/inhibitor
Biological sourceSARS coronavirus Urbani
Total number of polymer chains1
Total formula weight34790.80
Authors
Mesecar, A.D.,Center for Structural Genomics of Infectious Diseases (CSGID) (deposition date: 2020-03-30, release date: 2020-08-05, Last modification date: 2023-10-18)
Primary citationMesecar, A.D.
A taxonomically-driven approach to development of potent, broad-spectrum inhibitors of coronavirus main protease including SARS-CoV-2 (COVID-19)
To Be Published,
Experimental method
X-RAY DIFFRACTION (1.48 Å)
Structure validation

225158

PDB entries from 2024-09-18

PDB statisticsPDBj update infoContact PDBjnumon